Fig. 2From: Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United KingdomDrug survival curve of TG of patients receiving 20 mg TG per day compared to 40 mg/day. No significant differences were found between both curves (p = 0.57, Mantel-Cox test)Back to article page